COGT · Cogent Biosciences, Inc. · Executive Compensation
$26.72
-1.03 (-3.70%)
At close · Nov 20
Return incl. dividend (before tax)
Market Cap
$4.65B
Shares
173.99M
Volume · Nov 20
2.13M
Avg daily vol (3M)
2.08M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Andrew Robbins | Chief Executive Officer | $27,762,684 |
| Jessica Sachs | Chief Medical Officer | $9,178,177 |
| John Robinson | Chief Scientific Officer | $9,150,297 |
| Cole Pinnow | Chief Commercial Officer | $8,839,548 |
| John Green | Chief Financial Officer | $8,546,329 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Andrew Robbins | Chief Executive Officer | $4,917,890 |
| Cole Pinnow | Chief Commercial Officer | $3,969,744 |
| Jessica Sachs | Chief Medical Officer | $1,832,714 |
| John Robinson | Chief Scientific Officer | $1,807,431 |
| John Green | Chief Financial Officer | $1,747,767 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Andrew Robbins | Chief Executive Officer | $7,898,772 |
| Jessica Sachs | Chief Medical Officer | $2,999,941 |
| John Robinson | Chief Scientific Officer | $2,975,911 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Andrew Robbins | Chief Executive Officer | $4,391,176 |
| Jessica Sachs | Chief Medical Officer | $1,907,927 |
| John Robinson | Chief Scientific Officer | $1,869,151 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jessica Sachs | Chief Medical Officer | $3,809,193 |
| John Robinson | Chief Scientific Officer | $3,473,113 |
| Andrew Robbins | Chief Executive Officer | $2,862,878 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Andrew Robbins | Chief Executive Officer | $17,859,744 |
| John Green | Chief Financial Officer | $2,139,245 |
| Charles Wilson | Former Chief Executive Officer | $1,796,751 |
| Jessica Sachs | Chief Medical Officer | $1,189,457 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Charles Wilson | Former Chief Executive Officer | $1,717,416 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Todd Shegog | Director | Appointed | 2023-06-07 |
| Arlene M. Morris | Director | Appointed | 2023-06-07 |
| Chris Cain, Ph.D. | Director | Appointed | 2023-06-07 |
| Todd E. Shegog | Class II director | Appointed | 2021-02-22 |
Leadership
- Andrew Robbins CEO, Board Member
- Peter Harwin Chairman, Board Member
- John Green CFO
- John L. Green CFO
- Arlene M. Morris Board Member
- Chris Cain Board Member
- Chris Cain, Ph.D. Board Member
- Karen Ferrante Board Member
- Matthew E. Ros Board Member
- Todd E. Shegog Board Member
- Todd Shegog Board Member
Key facts
CIK
1622229
CUSIP
19240Q201
13F (30d)
323 filings
300 filers
Visit website
Investor relations